TRABECULAR BONE SCORE IN PATIENTS WITH CHRONIC GLUCOCORTICOID OSTEOPOROSIS TREATED WITH ALENDRONATE OR TERIPARATIDE

被引：0

作者：

Saag, K. G. ^{[1
]}

Agnusdei, D. ^{[2
]}

Hans, D. ^{[3
]}

Kohlmeier, L. A. ^{[4
]}

Krohn, K. D. ^{[5
]}

Leib, E. S. ^{[6
]}

Maclaughlin, E. J. ^{[7
]}

See, K. ^{[2
]}

Simonelli, C. ^{[8
]}

Taylor, K. A. ^{[5
]}

Marcus, R. ^{[9
]}

机构：

[1] Univ Alabama Birmingham, Dept Med, Div Rheumatol, Birmingham, AL 35294 USA

[2] Eli Lilly & Co, BMJ Platform Team, Indianapolis, IN 46285 USA

[3] Univ Lausanne Hosp, Ctr Bone Dis, Bone & Joint Dept, Lausanne, Switzerland

[4] Spokane Osteoporosis, Dept Endocrinol, Spokane, WA USA

[5] Lilly US, Indianapolis, IN USA

[6] Univ Vermont, Coll Med, Dept Med, Burlington, VT 05405 USA

[7] Edmund J MacLaughlin MD LLC, Cambridge, MD USA

[8] HealthEast Osteoporosis Care, St Paul, MN USA

[9] Stanford Univ, Dept Med, Stanford, CA 94305 USA

来源：

OSTEOPOROSIS INTERNATIONAL | 2015年 / 26卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P133

引用

页码：S84 / S85

页数：2

共 50 条

[1] Trabecular Bone Score in Patients With Chronic Glucocorticoid Therapy-Induced Osteoporosis Treated With Alendronate or Teriparatide
Saag, Kenneth G.
Agnusdei, Donato
Hans, Didier
Kohlmeier, Lynn A.
Krohn, Kelly D.
Leib, Edward S.
MacLaughlin, Edmund J.
Alam, Jahangir
Simonelli, Christine
Taylor, Kathleen A.
Marcus, Robert
[J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68 (09) : 2122 - 2128
[2] Bone formation markers in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate
Eastell, Richard
Chen, Peiqi
Saag, Kenneth G.
Burshell, Alan L.
Wong, Mayme
Warner, Margaret R.
Krege, John H.
[J]. BONE, 2010, 46 (04) : 929 - 934
[3] Effect of Teriparatide on Trabecular Bone Microarchitecture Assessed by the Trabecular Bone Score (TBS) in Patients with Osteoporosis
Davydov, Oksana
Hans, Didier
Bockman, Richard
[J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 : S320 - S320
[4] Correlations between bone turnover markers and BMD in patients treated with teriparatide or alendronate for glucocorticoid-induced osteoporosis
Burshell, A. L.
Moericke, R.
Correa-Rotter, R.
Chen, P.
Warner, M. R.
Krege, J. H.
[J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S128 - S128
[5] Serum osteocalcin concentrations in patients with glucocorticoid-induced osteoporosis treated with alendronate or teriparatide
Eastell, R.
Chen, P.
Saag, K. G.
Burshell, A. L.
Warner, M. R.
Dalsky, G. R.
Krege, J. H.
[J]. BONE, 2009, 44 (02) : S441 - S441
[6] Teriparatide or alendronate in glucocorticoid-induced osteoporosis
Babb, Richard R.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (12): : 1302 - 1303
[7] Teriparatide or alendronate in glucocorticoid-induced osteoporosis
Saag, Kenneth G.
Shane, Elizabeth
Boonen, Steven
Marin, Fernando
Donley, David W.
Taylor, Kathleen A.
Dalsky, Gail P.
Marcus, Robert
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (20): : 2028 - 2039
[8] Correlations between biochemical markers of bone turnover and bone density responses in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate
Burshell, Alan L.
Moericke, Ruediger
Correa-Rotter, Ricardo
Chen, Peiqi
Warner, Margaret R.
Dalsky, Gail P.
Taylor, Kathleen A.
Krege, John H.
[J]. BONE, 2010, 46 (04) : 935 - 939
[9] Metabolic bone diseases: Teriparatide or alendronate for glucocorticoid-induced osteoporosis therapy?
Nassabeh N.
[J]. Nature Reviews Rheumatology, 2010, 6 (1) : 1 - 1
[10] Baseline Glucocorticoid Dose and Bone Mineral Density Response with Teriparatide or Alendronate Therapy in Patients with Glucocorticoid-induced Osteoporosis
Devogelaer, Jean-Pierre
Adler, Robert A.
Recknor, Chris
See, Kyoungah
Warner, Margaret R.
Wong, Mayme
Krohn, Kelly
[J]. JOURNAL OF RHEUMATOLOGY, 2010, 37 (01) : 141 - 148

← 1 2 3 4 5 →